Latest Schedule 13G passive stakes

Peter E. Haas, Jr. filed an amended Schedule 13G disclosing beneficial ownership of 5.5% of Levi Strauss & Co. Class A Common Stock.

Citadel Advisors and related entities have filed a Schedule 13G reporting a 0.9% beneficial ownership stake in Atlas Critical Minerals Corporation.

Citadel Advisors and Kenneth Griffin have filed a Schedule 13G reporting a combined beneficial ownership of 2.8% in Allogene Therapeutics, Inc.

Pentwater Capital Management LP and Matthew Halbower have filed a Schedule 13G reporting a 9.99% beneficial ownership stake in AMC Entertainment Holdings, Inc.

Alyeska Investment Group, L.P. and affiliates have reported a 4.49% beneficial ownership stake in Spruce Biosciences, Inc. as of March 31, 2026.

RA Capital Management and its principals have reported an 8.9% beneficial ownership stake in Vaxcyte, Inc. as of March 31, 2026.

Investment firm Fourthstone LLC and its affiliates have reported a 9.98% beneficial ownership stake in F&M Bank Corp.

Jeffrey Tangney and Claudia Schweikert report continued significant beneficial ownership and voting control in Doximity, Inc.

Citadel Advisors and related entities report a negligible beneficial ownership of 13 shares in Acrivon Therapeutics.

Alyeska Investment Group, L.P. and Anand Parekh have filed a Schedule 13G reporting beneficial ownership of 2,689,789 shares of Sable Offshore Corp. common stock.

Investment firm Fourthstone LLC and its affiliates have reported a 9.83% beneficial ownership stake in Eagle Financial Services Inc.

Citadel Securities and affiliated entities have filed a Schedule 13G reporting a 6.5% beneficial ownership stake in Medifast, Inc.

Alyeska Investment Group, L.P. and associated parties have reported an 8.76% beneficial ownership stake in Brera Holdings PLC.

Tenor Capital Management and associated entities have filed a Schedule 13G reporting a 4% beneficial ownership stake in Paloma Acquisition Corp I.

Longitude Capital and its affiliates have reported a 7% beneficial ownership stake in CytomX Therapeutics, Inc.

Lingke Wang filed a Schedule 13G reporting beneficial ownership of 17.5% of Ethos Technologies Inc. Class A Common Stock.

Jennifer C. Haas has filed an amended Schedule 13G disclosing beneficial ownership of 18.2% of Levi Strauss & Co. Class A Common Stock.

RA Capital Management and its affiliates filed an amended Schedule 13G disclosing a 9.9% beneficial ownership stake in Unicycive Therapeutics, Inc. as of March 31, 2026.

Redmile Group, LLC and Jeremy C. Green have filed a Schedule 13G reporting a 5.6% beneficial ownership stake in AgomAb Therapeutics NV.

CastleKnight Master Fund LP and associated entities have filed a joint Schedule 13G amendment regarding their ownership stake in SunOpta Inc.

Nantahala Capital Management and its principals have reported a 9.99% beneficial ownership stake in Abeona Therapeutics Inc.

Encompass Capital Advisors and affiliates report a 4.23% beneficial ownership stake in National Energy Services Reunited Corp.

Peter George Colis has filed a Schedule 13G reporting beneficial ownership of 17.6% of Ethos Technologies Inc. Class A Common Stock.

Nantahala Capital Management, LLC has reported a 6.72% beneficial ownership stake in Herbalife Ltd. as of March 31, 2026.

Alyeska Investment Group, L.P. has filed a Schedule 13G reporting a 5.77% beneficial ownership stake in SKYX Platforms Corp.

First Light Asset Management and Mathew P. Arens have reported an 8.75% beneficial ownership stake in TriSalus Life Sciences, Inc. via a Schedule 13G filing.

Margaret E. Haas and the Margaret E. Haas Fund have filed an amended Schedule 13G disclosing beneficial ownership of 30.2% of Levi Strauss & Co. Class A Common Stock.

Nantahala Capital Management, LLC and its principals have reported a 6.28% beneficial ownership stake in Anteris Technologies Global Corp.

Nantahala Capital Management, LLC and its principals have reported a 9.99% beneficial ownership stake in InspireMD, Inc. as of March 31, 2026.

Alyeska Investment Group, L.P. and affiliates report a 0.04% beneficial ownership stake in Satellogic Inc. via warrant holdings.